5 SEPTEMBER, THURSDAY
0930
0945
Welcome to MedTech Forum 2024: The Dec-AI-de of Intelligent Healthcare Systems.
Jonathan S. Collard
Vice President, Global Government Affairs and Policy, Solventum
0945
1000
John Collings warmly welcomes delegates to Asia Pacific MedTech Forum 2024.
John Collings
Chairman, Board of Directors, APACMed,
President, Asia Pacific, Stryker
1000
1015
AI in Healthcare for a Smart Nation
The MedTech Industry is committed to supporting Singapore's goal of becoming a leading AI-enabled healthcare hub in Asia. This aligns with the government’s aim in establishing the MedTech Industry as one of its AI Peaks of Excellence under the Singapore National AI Strategy 2.0. Through strong collaboration, we can leverage AI to improve population health while generating significant economic benefits.
Ms Low Yen Ling
Senior Minister of State, Ministry of Trade & Industry and Ministry of Culture, Community & Youth
1015
1130
Forging a New Era of Access in Healthcare Through Education and Technology
Education is a cornerstone of healthcare as informed communities are healthier communities. Join Nobel Laureate Malala Yousafzai who will discuss the transformative potential of education and technology in achieving better national health outcomes and enhancing healthcare access for millions. Her insights can inspire a broader view of patient care and serve as a crucial starting point for policymakers, healthcare practitioners, medical technology companies and other stakeholders to explore how they might innovate and collaborate to create optimal conditions in a new era of Al-enabled healthcare access.
Malala Yousafzai
Nobel Laureate,
Co-Founder, Malala Fund
Sharanjit Leyl
International Moderator Chancellor, Bath Spa University
1130
1230
Hacking Healthcare
Join Tom Lawry, AI transformation expert, as he delves into the most impactful drivers of AI in revolutionising healthcare for positive change, leveraging examples that bridge theory with practice. Discover how AI streamlines healthcare processes, enhances patient outcomes, reduces costs, improves efficiency and more.
Tom will draw from his award-winning book "Hacking Healthcare” and offer actionable strategies and real-world case studies to illustrate practical applications.
Tom Lawry
Best-Selling Author, AI Transformation Advisor & Managing Director, Second Century Tech
1230
1400
Lunch Dialogues
Parallel Sessions
Dialogue Den A
The MedTech Industry is crucial in saving lives, enhancing quality of life, and significantly impacting societies and governments.
How can we better tell our stories to create an emotional connection with our target audiences, and convey the true value and importance of our industry and the benefits we bring to patients in their countries?
Join us for a masterclass to learn strategies for mastering the art of storytelling in MedTech.
Matthew Luhn
Fortune 500 Storytelling Consultant,
Disney/Pixar Veteran behind Toy Story, Monsters Inc., Finding Nemo and more
Dialogue Den C
MedTech innovations in Asia are accelerating, improving in quantity and quality. Can these innovations be developed faster and enter other global markets? What are the reasons behind companies successfully innovating in these markets, and how can these companies continue to thrive? Learn about the exciting advancements in MedTech in this part of the world.
Alicia Chang
Country Lead, China,
APACMed
Feng Dong
Board Member,
APACMed,
Vice President, Asian Region-Led Markets, Global Regions,
Medtronic
Kenneth Goh
Scientific Portfolio Engagement Lead, JLABS Singapore,
Johnson & Johnson
Baoshan Li
Vice President, Secretary General,
Hospital Construction and Equipment Branch of the China Association of Medical Equipment
Adip Puri
Country Lead, India,
APACMed
Dr. Shravan Subramanyam
Advisor, Healthcare and Med-tech Investments,
Premji Invest
Jody Tian
Partner, Hong Kong,
McKinsey & Company
Kevin Wu
Partner, Shanghai,
McKinsey & Company
Dr. Ivy Zhang
Founder, Chief Executive Officer,
MAXIGHT Technology Singapore,
Co-founder, Chief Technology Officer,
Shanghai Ruishi Health Technology
Dialogue Den B
In the land of Healthcare and MedTech so fine,
AI Ethics play a role that's simply divine.
From patient to doctor, from nurse to machine,
Let's explore what it means to keep ethics pristine!
Much like the whimsical world of Dr. Seuss, AI's evolving impact on Healthcare is full of loops and hoops, making it challenging for Ethics to keep pace. Dive into the windings of protecting confidentiality, ensuring fairness, obtaining consent, and maintaining transparency. Let's discuss what happens when the ethical balance teeters.
Dr. LaMont Bryant
Vice President, Global Government Affairs and Market Access,
Stryker
Punit Kohli
Board Member,
APACMed,
Vice President-Commercial Operations, Asia Pacific,
Fresenius Medical Care
Dr. Liu Nan
Director, Duke-NUS AI + Medical Sciences Initiative (DAISI), Associate Professor, Centre for Quantitative Medicine,
Duke-NUS Medical School
Lucas Nicolet-Serra
Counsel,
K&L Gates Straits Law LLC
JyeMei Wong
Regional Senior Legal & Compliance Counsel, APAC,
Boston Scientific
Dialogue Den A
The MedTech Industry is crucial in saving lives, enhancing quality of life, and significantly impacting societies and governments.
How can we better tell our stories to create an emotional connection with our target audiences, and convey the true value and importance of our industry and the benefits we bring to patients in their countries?
Join us for a masterclass to learn strategies for mastering the art of storytelling in MedTech.
Matthew Luhn
Fortune 500 Storytelling Consultant,
Disney/Pixar Veteran behind Toy Story, Monsters Inc., Finding Nemo and more
Dialogue Den B
In the land of Healthcare and MedTech so fine,
AI Ethics play a role that's simply divine.
From patient to doctor, from nurse to machine,
Let's explore what it means to keep ethics pristine!
Much like the whimsical world of Dr. Seuss, AI's evolving impact on Healthcare is full of loops and hoops, making it challenging for Ethics to keep pace. Dive into the windings of protecting confidentiality, ensuring fairness, obtaining consent, and maintaining transparency. Let's discuss what happens when the ethical balance teeters.
Dr. LaMont Bryant
Vice President, Global Government Affairs and Market Access,
Stryker
Punit Kohli
Board Member,
APACMed,
Vice President-Commercial Operations, Asia Pacific,
Fresenius Medical Care
Dr. Liu Nan
Director, Duke-NUS AI + Medical Sciences Initiative (DAISI), Associate Professor, Centre for Quantitative Medicine,
Duke-NUS Medical School
Lucas Nicolet-Serra
Counsel,
K&L Gates Straits Law LLC
JyeMei Wong
Regional Senior Legal & Compliance Counsel, APAC,
Boston Scientific
Dialogue Den C
MedTech innovations in Asia are accelerating, improving in quantity and quality. Can these innovations be developed faster and enter other global markets? What are the reasons behind companies successfully innovating in these markets, and how can these companies continue to thrive? Learn about the exciting advancements in MedTech in this part of the world.
Alicia Chang
Country Lead, China,
APACMed
Feng Dong
Board Member,
APACMed,
Vice President, Asian Region-Led Markets, Global Regions,
Medtronic
Kenneth Goh
Scientific Portfolio Engagement Lead, JLABS Singapore,
Johnson & Johnson
Baoshan Li
Vice President, Secretary General,
Hospital Construction and Equipment Branch of the China Association of Medical Equipment
Adip Puri
Country Lead, India,
APACMed
Dr. Shravan Subramanyam
Advisor, Healthcare and Med-tech Investments,
Premji Invest
Jody Tian
Partner, Hong Kong,
McKinsey & Company
Kevin Wu
Partner, Shanghai,
McKinsey & Company
Dr. Ivy Zhang
Founder, Chief Executive Officer,
MAXIGHT Technology Singapore,
Co-founder, Chief Technology Officer,
Shanghai Ruishi Health Technology
1230
1400
By Invitation Only
1400
1500
The Power of Transformative Storytelling in Healthcare
Matthew Luhn, acclaimed storyteller and former Pixar Animation Studios creative consultant, will showcase the transformative power of storytelling in healthcare. Through captivating anecdotes and sharing of practical techniques, attendees will gain insights into crafting narratives that resonate, evoke emotion, and inspire action.
Matthew will demonstrate how compelling storytelling can captivate stakeholders and drive meaningful engagement, ensuring MedTech’s impact is recognised and valued.
Matthew Luhn
Fortune 500 Storytelling Consultant,
Disney/Pixar Veteran behind Toy Story, Monsters Inc., Finding Nemo and more
1500
1545
View from the Top - Accelerating Growth in Asia
In this session, Stephen Sunderland from L.E.K. will moderate a discussion with Vladimir Makatsaria and Supratim Bose, founding members of APACMed. The conversation will explore the vision to collectively shape the future of healthcare in the Asia Pacific, as well as the founding goal to accelerate access to innovative medical technologies and cutting-edge healthcare solutions throughout the region. The panellists will share their insights and strategies for driving growth as a MedTech business in Asia, discussing effective initiatives and future opportunities.
Supratim Bose
Chief Executive Officer, CMR Surgical
Vladimir Makatsaria
Chief Executive Officer, LivaNova,
Board Member, AdvaMed
Stephen Sunderland
Head, APAC Healthcare and Life Sciences, Partner, L.E.K. Consulting Singapore
1545
1630
Is AI Delivering Better Patient Outcomes or Just Overhyped?
A thought-provoking exploration of AI's real impact on patient outcomes. Renowned clinical professor, Dr. Brent James, will share his insights on transforming healthcare systems through innovative approaches and cutting-edge research. With a distinguished career dedicated to revolutionising healthcare delivery, Dr. James has been instrumental in driving quality improvement and efficiency on a global scale.
To unlock the full potential of AI for patient care, Dr. James and a distinguished panel of experts will delve into the critical questions surrounding this transformative technology. They will explore real-world applications, assess challenges and opportunities, and debate how to optimise AI's integration into healthcare systems while preserving the essential human touch in patient care.
Dr. Brent James
Clinical Professor,
Clinical Excellence Research Center (CERC),
Department of Medicine, Stanford University School of Medicine
A/Prof Tam C. Nguyen
Deputy Director of Research,
St Vincent's Hospital Melbourne, Associate Professor, Melbourne Medical School
Slobodan Radumilo
SVP, President International,
Embecta,
Chair, Diabetes Sector Group, MedTech Europe
Anastasia Miros
Director, Healthcare and Life Sciences, KPMG Asia Pacific
1630
1640
We wrap up the day’s sessions and invite our delegates to join us at our 10th Anniversary Party.
Jonathan S. Collard
Vice President, Global Government Affairs and Policy, Solventum
1640
1755
Meet the MedTech Innovator APAC Finalists 2024 and cast your vote to select this year’s Grand Prize Winner of USD 175,000 in cash. Additional prizes to be given include JLABS Award, Cambridge Consultants’ Design & Development Award, EnterpriseSG Grant Award, Best Video Award which, when combined with the Grand Prize, total more than USD 300,000.
Paul Grand
Chief Executive Officer, MedTech Innovator
Ashley Wittorf
Head of Business Development, Asia Pacific, Johnson & Johnson MedTech
Vy Tran
Board Member,
APACMed,
President of Asia Pacific and Japan, Siemens Healthineers
Raphael Ong
APAC Director, Strategy, Marketing and Commercial Excellence, Teleflex
1830
2030
We celebrate a decade of progress at the APACMed 10th Anniversary Party. Join us at Clifford Pier for an unforgettable evening.
John Collings
Chairman, Board of Directors, APACMed,
President, Asia Pacific, Stryker
Harjit Gill
Chief Executive Officer, APACMed
Jonathan S. Collard
Vice President, Global Government Affairs and Policy, Solventum
Vladimir Makatsaria
Chief Executive Officer, LivaNova,
Board Member, AdvaMed
6 SEPTEMBER, FRIDAY
0900
1015
Breakfast Dialogues
Parallel Sessions
Dialogue Den A
Despite the rise of AI, healthcare remains fundamentally human-centred, with technology enhancing rather than replacing human expertise, even amidst workforce challenges in the Asia Pacific. We will explore AI's impact on the workforce, including the profiles and skills required for a smarter healthcare ecosystem. Hands-on AI training will help participants upskill, with a special focus on AI tools that support more efficient collaboration.
Tom Lawry
Best-Selling Author, AI Transformation Advisor & Managing Director,
Second Century Tech
Dr. Chris L. Hardesty
Strategic Advisor,
APACMed
Dr. Harshad Jadhav
Senior Director, HR, Sports Medicine, International Markets,
Smith+Nephew
Ozanan R. Meireles
MD, FACS
Associate Professor of Surgery,
Duke University School of Medicine, Department of Surgery
Brian D. Mitchell
Asia Area Leader,
Health Information Systems,
Country Director of Australia and New Zealand,
Solventum
Ajay Nair
President,
The Mullings Group
Steven Truong
Founder, Chief Executive Officer,
VinBrain
Dialogue Den C
Diagnostic testing is at the core of every healthcare system, and thus to ensure we are optimizing value across the patient care spectrum we must ensure we are making the correct investments in testing. In this session, we will look across Asia Pacific to understand how game changing biomarkers are being adopted across disease states, what the key barriers are that are slowing adoption, how we can drive out inefficiency in diagnostic delivery, and options for optimizing resource allocation. The conversation will leverage data to help us discuss with our panel of experts about key actions to ensure patients have timely access to best-in-class biomarkers.
Dr. Regina Berba
Chair, Hospital Infection Control Unit and Antimicrobial Stewardship Committee,
University of the Philippines General Hospital
Alec M. Lee
Managing Director Healthcare,
FrontierView
Saurabh Rajadhyax
Senior Vice President, Clinical Operations Asia Pacific,
bioMérieux
Prof. K. Srinath Reddy
Founder (Past) President, Honorary Distinguished Professor of Public Health,
Public Health Foundation of India
Joanna Sickler
Vice-President, Health Policy and External Affairs,
Roche Diagnostics USA
Dialogue Den B
Don't miss this opportunity to gain firsthand insights from top MedTech regulators across the Asia Pacific region. In this session, regulators will share updates on the regulatory landscape and key priorities for 2025.
Tracey Duffy
First Assistant Secretary, Medical Devices and Product Quality Division,
Therapeutic Goods Administration Australia
Anle Lin
Acting Assistant Director,
Digital Health Branch, Medical Devices Cluster, Health Products Regulation,
Health Sciences Authority
Daniel Moelands
Vice President, Regulatory Affairs,
Johnson & Johnson MedTech Asia Pacific
Madoka Murakami
Principal Reviewer,
Pharmaceuticals and Medical Devices Agency
Dr. Muralitharan Paramasua
Chief Executive,
Medical Device Authority, Ministry of Health Malaysia
Mi-Jung Son
Director, Digital Medical Products Task Force,
Ministry of Food and Drug Safety (MFDS), Republic of Korea
Start-up Zone
Opportunity for an exclusive networking opportunity tailored for selected start-ups and investors, particularly those focused on mature innovations. This session will feature a Fireside Chat: Investor Perspective in U.S. Market with Daniel Teo, Managing Director of Hunniwell Lake Ventures, and Fredrik Nyberg, Managing Director MedTech Innovator Asia Pacific. Additionally, you'll hear brief pitches from promising start-ups in the U.S. Market Access Cohort:
- Adrian Ang, CEO from AEvice Health
- Dr. Zhunan Jia, CEO from Breathonix
- Abel Teo, CEO from Castomize
- Tai Lim Tan, Head, Chairman's Office / Vice President from Credo Diagnostics
- Stephen Lim, CEO from FathomX
- Alan Goh, CEO from NDR Medical Technology
- Pang Sze-Yunn, CEO from Neurowyzr
- Dr. Anthony Chua, CEO & Co-Founder from Stratificare
- Shavit Clein, CEO from Thrixen
Fredrik Nyberg
Managing Director,
MedTech Innovator Asia Pacific
Daniel Teo
Managing Director,
Hunniwell Lake Ventures
Dialogue Den A
Despite the rise of AI, healthcare remains fundamentally human-centred, with technology enhancing rather than replacing human expertise, even amidst workforce challenges in the Asia Pacific. We will explore AI's impact on the workforce, including the profiles and skills required for a smarter healthcare ecosystem. Hands-on AI training will help participants upskill, with a special focus on AI tools that support more efficient collaboration.
Tom Lawry
Best-Selling Author, AI Transformation Advisor & Managing Director,
Second Century Tech
Dr. Chris L. Hardesty
Strategic Advisor,
APACMed
Dr. Harshad Jadhav
Senior Director, HR, Sports Medicine, International Markets,
Smith+Nephew
Ozanan R. Meireles
MD, FACS
Associate Professor of Surgery,
Duke University School of Medicine, Department of Surgery
Brian D. Mitchell
Asia Area Leader,
Health Information Systems,
Country Director of Australia and New Zealand,
Solventum
Ajay Nair
President,
The Mullings Group
Steven Truong
Founder, Chief Executive Officer,
VinBrain
Dialogue Den B
Don't miss this opportunity to gain firsthand insights from top MedTech regulators across the Asia Pacific region. In this session, regulators will share updates on the regulatory landscape and key priorities for 2025.
Tracey Duffy
First Assistant Secretary, Medical Devices and Product Quality Division,
Therapeutic Goods Administration Australia
Anle Lin
Acting Assistant Director,
Digital Health Branch, Medical Devices Cluster, Health Products Regulation,
Health Sciences Authority
Daniel Moelands
Vice President, Regulatory Affairs,
Johnson & Johnson MedTech Asia Pacific
Madoka Murakami
Principal Reviewer,
Pharmaceuticals and Medical Devices Agency
Dr. Muralitharan Paramasua
Chief Executive,
Medical Device Authority, Ministry of Health Malaysia
Mi-Jung Son
Director, Digital Medical Products Task Force,
Ministry of Food and Drug Safety (MFDS), Republic of Korea
Dialogue Den C
Diagnostic testing is at the core of every healthcare system, and thus to ensure we are optimizing value across the patient care spectrum we must ensure we are making the correct investments in testing. In this session, we will look across Asia Pacific to understand how game changing biomarkers are being adopted across disease states, what the key barriers are that are slowing adoption, how we can drive out inefficiency in diagnostic delivery, and options for optimizing resource allocation. The conversation will leverage data to help us discuss with our panel of experts about key actions to ensure patients have timely access to best-in-class biomarkers.
Dr. Regina Berba
Chair, Hospital Infection Control Unit and Antimicrobial Stewardship Committee,
University of the Philippines General Hospital
Alec M. Lee
Managing Director Healthcare,
FrontierView
Saurabh Rajadhyax
Senior Vice President, Clinical Operations Asia Pacific,
bioMérieux
Prof. K. Srinath Reddy
Founder (Past) President, Honorary Distinguished Professor of Public Health,
Public Health Foundation of India
Joanna Sickler
Vice-President, Health Policy and External Affairs,
Roche Diagnostics USA
Start-up Zone
Opportunity for an exclusive networking opportunity tailored for selected start-ups and investors, particularly those focused on mature innovations. This session will feature a Fireside Chat: Investor Perspective in U.S. Market with Daniel Teo, Managing Director of Hunniwell Lake Ventures, and Fredrik Nyberg, Managing Director MedTech Innovator Asia Pacific. Additionally, you'll hear brief pitches from promising start-ups in the U.S. Market Access Cohort:
- Adrian Ang, CEO from AEvice Health
- Dr. Zhunan Jia, CEO from Breathonix
- Abel Teo, CEO from Castomize
- Tai Lim Tan, Head, Chairman's Office / Vice President from Credo Diagnostics
- Stephen Lim, CEO from FathomX
- Alan Goh, CEO from NDR Medical Technology
- Pang Sze-Yunn, CEO from Neurowyzr
- Dr. Anthony Chua, CEO & Co-Founder from Stratificare
- Shavit Clein, CEO from Thrixen
Fredrik Nyberg
Managing Director,
MedTech Innovator Asia Pacific
Daniel Teo
Managing Director,
Hunniwell Lake Ventures
1015
1030
Scott Montgomery
Chief Executive Officer, Managing Director, Advanced Health Intelligence Ltd
1030
1100
Harnessing AI for Growth through Innovation and Partnerships
In an age of disruptions, a paradigm shift in the way organisations operate is imperative for sustainable growth. Art Butcher shares his visionary outlook on the future of the MedTech industry in Asia, transcending corporate boundaries, to offer insights aimed at benefiting the industry as a whole.
Arthur C. Butcher
Executive Vice President & Group President, MedSurg and Asia Pacific, Boston Scientific
1100
1145
Future Proofing with AI Talent
With or without AI, healthcare remains inherently human-centred. Technology will complement but never replace human expertise – even with persistent workforce challenges in the Asia Pacific. In this session, we will look at AI's impact on the workforce, including the profiles and skills required for a more intelligent healthcare ecosystem to function. Our panellists will discuss the essential skills for organisations to remain agile and resilient, along with cultural transformations needed for innovation and collaboration.
Vikram Kapur
Global Head of Healthcare and Life Sciences Practice, Bain & Company
Vy Tran
Board Member,
APACMed,
President of Asia Pacific and Japan, Siemens Healthineers
John Collings
Chairman, Board of Directors, APACMed,
President, Asia Pacific, Stryker
John Eng
Vice President Healthcare, Singapore Economic Development Board
1145
1230
The Ethical Dilemma of AI
Our panellists will discuss the revolutionary potential of AI in the healthcare landscape while delving into the ethical challenges and dilemmas it presents. They will discuss the principles of ethical AI, including fairness, transparency, and patient privacy, and how these can be integrated into AI development and deployment.
Through real-world case studies, they will examine the successes and pitfalls of AI in healthcare, offering insights into best practices and regulatory considerations. Navigate the exciting and complex world of AI in healthcare, ensuring innovation goes hand in hand with integrity with us.
Paul R. Haswell
Partner, K&L Gates
Dr. Monica Trujillo
Chief Health Officer, Telstra Health
Leonard Ong
Director, Policy, Risk Management and Capability Development, Synapxe
Christian Fitsch
Chair, Legal, Ethics and Compliance Committee,
APACMed,
VP & Chief Legal Counsel APAC, Stryker
1200
1400
1230
1315
Unlocking Data and AI for Enhanced Public Healthcare Delivery
Our panellists discuss the potential of AI to optimise operations, address talent shortages, and enhance disease prevention for improved population health management. As the industry grapples with chronic staff shortages and burnout, innovative solutions are imperative. How far-reaching can AI's impact be in pushing healthcare boundaries?
Ozanan R. Meireles
MD, FACS
Associate Professor of Surgery, Duke University School of Medicine,
Department of Surgery
Prof. K. Srinath Reddy
Founder (Past) President, Honorary Distinguished Professor of Public Health, Public Health Foundation of India
Farhana Nakhooda
Board Member,
APACMed,
General Manager & Senior Vice President, Asia Pacific, Health Catalyst
Jodi Eddy
Senior Vice President, Chief Information and Digital Officer, Boston Scientific
Sutowo Wong
Director, Health Analytics Division, Ministry of Health Singapore
1315
1325
We wrap up the day’s sessions and invite our delegates to the Dialogue Dens.
Scott Montgomery
Chief Executive Officer, Managing Director, Advanced Health Intelligence Ltd
1325
1500
Lunch Dialogues
Parallel Sessions
Dialogue Den A
The transition to value-based healthcare relies heavily on data analytics for measuring patient outcomes and identifying cost drivers. Health data plays a vital role in this process. However, fragmented ownership and accessibility issues hinder stakeholders’ access to vast volumes of data, which could potentially yield valuable insights.
Hospitals, governments, MedTech and technology companies, and even patients, each hold a piece of the health data puzzle.
Find out why it is important to have common data and cybersecurity standards and why the industry and government must collaborate to unlock the latent value of health data.
Dr. Adam Chee
Associate Professor,
Saw Swee Hock School of Public Health,
National University of Singapore
Anastasia Miros
Director, Healthcare and Life Sciences,
KPMG Asia Pacific
Farhana Nakhooda
Board Member,
APACMed,
General Manager & Senior Vice President, Asia Pacific,
Health Catalyst
A/Prof Tam C. Nguyen
Deputy Director of Research,
St Vincent's Hospital Melbourne, Associate Professor,
Melbourne Medical School
Su Fen Ong
Lead, Health Data,
APACMed
Dialogue Den C
Localisation is the new paradigm in Asia. Understanding its trends and implications is crucial for business leaders aiming to thrive in this evolving environment. Can these dynamics be leveraged as an advantage?
Explore how companies leverage strategic localisation to mitigate risks. Identify niches, and transform localisation into a competitive advantage through case studies.
Benish Aslam
Lead, Government Affairs and Policy & ESG,
APACMed
Probir Das
Vice Chairman, Board of Directors,
APACMed,
Group Executive Officer,
Terumo Corporation
Majid Kaddoumi
Senior Vice President and President,
Medtronic EurAsia
Vikram Kapur
Global Head of Healthcare and Life Sciences Practice,
Bain & Company
Dialogue Den B
Explore the pivotal role of pricing reforms in connecting the latest global medical advancements with the specific needs of local healthcare systems. We'll discuss the importance of adapting pricing reform practices to different global contexts, ensuring equitable access to effective and affordable medical technologies for all.
By merging global strategies with local realities, we can enhance healthcare outcomes worldwide. Join us to discuss how innovative medical solutions can reach those who need them most, regardless of location or economic background.
Ellil Mathiyan Lakshmanan
President,
Ostomy Association of Singapore
Pavan Mocherla
Board Member,
APACMed,
Executive Vice President, President Greater Asia,
Becton Dickinson
Markus Siebert
Senior Director, Health Economics and Reimbursement,
Abbott
Dr. Dilpreet Singh
Partner, JAPAC Head,
Clarivate
Dialogue Den A
The transition to value-based healthcare relies heavily on data analytics for measuring patient outcomes and identifying cost drivers. Health data plays a vital role in this process. However, fragmented ownership and accessibility issues hinder stakeholders’ access to vast volumes of data, which could potentially yield valuable insights.
Hospitals, governments, MedTech and technology companies, and even patients, each hold a piece of the health data puzzle.
Find out why it is important to have common data and cybersecurity standards and why the industry and government must collaborate to unlock the latent value of health data.
Dr. Adam Chee
Associate Professor,
Saw Swee Hock School of Public Health,
National University of Singapore
Anastasia Miros
Director, Healthcare and Life Sciences,
KPMG Asia Pacific
Farhana Nakhooda
Board Member,
APACMed,
General Manager & Senior Vice President, Asia Pacific,
Health Catalyst
A/Prof Tam C. Nguyen
Deputy Director of Research,
St Vincent's Hospital Melbourne, Associate Professor,
Melbourne Medical School
Su Fen Ong
Lead, Health Data,
APACMed
Dialogue Den B
Explore the pivotal role of pricing reforms in connecting the latest global medical advancements with the specific needs of local healthcare systems. We'll discuss the importance of adapting pricing reform practices to different global contexts, ensuring equitable access to effective and affordable medical technologies for all.
By merging global strategies with local realities, we can enhance healthcare outcomes worldwide. Join us to discuss how innovative medical solutions can reach those who need them most, regardless of location or economic background.
Ellil Mathiyan Lakshmanan
President,
Ostomy Association of Singapore
Pavan Mocherla
Board Member,
APACMed,
Executive Vice President, President Greater Asia,
Becton Dickinson
Markus Siebert
Senior Director, Health Economics and Reimbursement,
Abbott
Dr. Dilpreet Singh
Partner, JAPAC Head,
Clarivate
Dialogue Den C
Localisation is the new paradigm in Asia. Understanding its trends and implications is crucial for business leaders aiming to thrive in this evolving environment. Can these dynamics be leveraged as an advantage?
Explore how companies leverage strategic localisation to mitigate risks. Identify niches, and transform localisation into a competitive advantage through case studies.
Benish Aslam
Lead, Government Affairs and Policy & ESG,
APACMed
Probir Das
Vice Chairman, Board of Directors,
APACMed,
Group Executive Officer,
Terumo Corporation
Majid Kaddoumi
Senior Vice President and President,
Medtronic EurAsia
Vikram Kapur
Global Head of Healthcare and Life Sciences Practice,
Bain & Company
1500
1700
Networking Dialogues
Parallel Sessions
Dialogue Den A
This session unravels the historical, societal, and systemic threads that weave the complex issue of hidden disparities in women’s health. Our expert panelists will share their professional insights, shedding light on the often-overlooked and unique symptoms that women face. Discover the unique challenges that female healthcare professionals encounter in their fight to bring women's health to the forefront.
Be inspired to drive actionable change with practical strategies, making a tangible impact in closing the gender gap in healthcare.
Dr. Jennifer Green
Founder, Board Member,
International Orthopaedic Diversity Alliance
Lance Little
Board Member,
APACMed,
Head of Region,
Roche Diagnostics Asia Pacific
Alicia Yi
Vice Chair, Global Consumer Market,
Korn Ferry
Dialogue Den C
Get ready for a candid and authentic conversation with our exceptional C-suite leaders. This isn't just another panel, it's a chance to hear the personal stories of our industry’s top minds in a truly interactive session.
What transformative lessons have they gained through failures? What are their most meaningful achievements and the impact those moments had on their careers? Hear anecdotes that reveal their motivations and drive.
Get up-close, get inspired.
Probir Das
Vice Chairman, Board of Directors,
APACMed,
Group Executive Officer,
Terumo Corporation
Punit Kohli
Board Member,
APACMed,
Vice President-Commercial Operations, Asia Pacific,
Fresenius Medical Care
Vy Tran
Board Member,
APACMed,
President of Asia Pacific and Japan,
Siemens Healthineers
Ulrike Wieduwilt
Managing Director/ Partner,
Russell Reynolds Associates
Dialogue Den B
As Medical Device companies navigate the complexities of international markets, establishing local manufacturing footprints and addressing the complexities of global supply chains, finding the right contract manufacturing partner becomes paramount. How can governments help to build a thriving ecosystem for manufacturing locally for scalability? How can contract manufacturers build on their capabilities to meet the needs of the sector?
Find out more in this session.
John Collings
Chairman, Board of Directors, APACMed,
President, Asia Pacific,
Stryker
John Eng
Vice President Healthcare,
Singapore Economic Development Board
Asst. Prof Enci Mary Kan
Director, MedTech, I&E-BMRC-SERC and Programme Director, MedTech Catapult,
A*STAR
Meng Hwee Koh
Senior Director, Head APAC Business Development Health Solutions Business Group,
Flex Health Solutions
Richard Lieu
Head of Technology,
Vivo Surgical
Dialogue Den A
This session unravels the historical, societal, and systemic threads that weave the complex issue of hidden disparities in women’s health. Our expert panelists will share their professional insights, shedding light on the often-overlooked and unique symptoms that women face. Discover the unique challenges that female healthcare professionals encounter in their fight to bring women's health to the forefront.
Be inspired to drive actionable change with practical strategies, making a tangible impact in closing the gender gap in healthcare.
Dr. Jennifer Green
Founder, Board Member,
International Orthopaedic Diversity Alliance
Lance Little
Board Member,
APACMed,
Head of Region,
Roche Diagnostics Asia Pacific
Alicia Yi
Vice Chair, Global Consumer Market,
Korn Ferry
Dialogue Den B
As Medical Device companies navigate the complexities of international markets, establishing local manufacturing footprints and addressing the complexities of global supply chains, finding the right contract manufacturing partner becomes paramount. How can governments help to build a thriving ecosystem for manufacturing locally for scalability? How can contract manufacturers build on their capabilities to meet the needs of the sector?
Find out more in this session.
John Collings
Chairman, Board of Directors, APACMed,
President, Asia Pacific,
Stryker
John Eng
Vice President Healthcare,
Singapore Economic Development Board
Asst. Prof Enci Mary Kan
Director, MedTech, I&E-BMRC-SERC and Programme Director, MedTech Catapult,
A*STAR
Meng Hwee Koh
Senior Director, Head APAC Business Development Health Solutions Business Group,
Flex Health Solutions
Richard Lieu
Head of Technology,
Vivo Surgical
Dialogue Den C
Get ready for a candid and authentic conversation with our exceptional C-suite leaders. This isn't just another panel, it's a chance to hear the personal stories of our industry’s top minds in a truly interactive session.
What transformative lessons have they gained through failures? What are their most meaningful achievements and the impact those moments had on their careers? Hear anecdotes that reveal their motivations and drive.
Get up-close, get inspired.
Probir Das
Vice Chairman, Board of Directors,
APACMed,
Group Executive Officer,
Terumo Corporation
Punit Kohli
Board Member,
APACMed,
Vice President-Commercial Operations, Asia Pacific,
Fresenius Medical Care
Vy Tran
Board Member,
APACMed,
President of Asia Pacific and Japan,
Siemens Healthineers
Ulrike Wieduwilt
Managing Director/ Partner,
Russell Reynolds Associates
5 SEPTEMBER, THURSDAY
0930
0945
Welcome to APAC MedTech Forum 2024
0945
1000
Chairman Opening Address
1000
1015
Gracing by Singapore Guest-of-Honour
AI in Healthcare for a Smart Nation
1015
1130
Fireside Chat
Forging a New Era of Access in Healthcare Through Education and Technology
1130
1230
Keynote
Hacking Healthcare
1230
1400
Lunch Dialogues
Dialogue Den A
Masterclass on the Art of Storytelling for MedTech
Dialogue Den B
AI in Healthcare & MedTech - Ethics to Care, Ethics to Share!
Dialogue Den C
Unleashing the Innovative Power of Asia
Start-up Zone
- APACMed "State of Innovation Financing" Report Launch
- The Realities of Today’s Funding Landscape for MedTech Founders
- MedTech Actuator Accelerator Start-up Pitches
- Championing Change – Elevating Early-Stage Female Health Innovators
1230
1400
The Great AI Lunch Debate by KPMG
1400
1500
Keynote
The Power of Transformative Storytelling in Healthcare
1500
1545
Panel Discussion
View from the Top - Accelerating Growth in Asia
1545
1630
Keynote & Panel Discussion
Is AI Delivering Better Patient Outcomes or Just Overhyped?
1630
1640
Day 1 Round Up
1640
1755
MedTech Innovator Grand Finals
1830
2030
APACMed 10th Anniversary Party
6 SEPTEMBER, FRIDAY
0900
1015
Breakfast Dialogues
Dialogue Den A
The Future of Healthcare is Intelligent, Are You?
Dialogue Den B
RegConnect - In Conversation with Asia Pacific's Regulators
Dialogue Den C
Supercharging Diagnostic Testing Across Asia Pacific
Start-up Zone
MedTech Innovator Networking Breakfast
1015
1030
Welcome
1030
1100
Keynote
Harnessing AI for Growth through Innovation and Partnerships
1100
1145
Panel Discussion
Future Proofing with AI Talent
1145
1230
Panel Discussion
The Ethical Dilemma of AI
1200
1400
Delivering Manufacturing Excellence for Advanced MedTech Products - Lunch by Enterprise Singapore
1230
1315
Panel Discussion
Unlocking Data and AI for Enhanced Public Healthcare Delivery
1315
1325
Day 2 Round Up
1325
1500
Lunch Dialogues
Dialogue Den A
Who Let the Data Out?
Dialogue Den B
Can Pricing Reforms Deliver Health Equity?
Dialogue Den C
Strategic Localisation - Challenges and Opportunities in Asia
Start-up Zone
- APACMed Innovation Community Welcome
- MedTech Innovator Showcase Panels
1500
1700
Networking Dialogues
Dialogue Den A
Closing the Gender Gap in Women's Healthcare
Dialogue Den B
Building a Manufacturing Ecosystem for Scalability
Dialogue Den C
CEO #Unfiltered
Start-up Zone
- MedTech Innovator Showcase Panels
